GENEVA, Aug. 31 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2026/015869) for “METHODS OF ANALYZING PROTEIN THERAPEUTICS UNDER NATIVE CONDITIONS”. With publication no. WO/2026/178252, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G01N 33/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....